Latent CMV And EBV Infections And The Mobilization Of Viral-specific And Senescent T-cells With Exercise

被引：0
|
作者：
Simpson, Richard J. [1 ]
Spielmann, Guillaume [1 ]
Bigley, Austin B. [1 ]
Rector, Jerrald L. [1 ]
Bartlett, David B. [1 ]
Morrison, Mark R. [1 ]
机构：
[1] Univ Houston, Houston, TX USA
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2011年 / 43卷 / 05期
关键词：
D O I：
10.1249/01.MSS.0000401343.81353.00
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
1943
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [31] VIRUS SPECIFIC T-CELLS AGAINST ADV, EBV AND CMV IN INFECTED MULTI-TREATED POST-HSCT PATIENTS
    Leroyer, Esther Hazane
    Bensoussan, Daniele
    D'Aveni, Maud
    Dalle, Jean Hugues
    Petitpain, Nadine
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 240 - 241
  • [32] Generation of tri-specific cytotoxic T-cells recognizing adenovirus, EBV and CMV: A novel approach to adoptive immunotherapy.
    Amrolia, PJ
    Sili, U
    Leen, A
    Brenner, MK
    Rooney, C
    BLOOD, 2002, 100 (11) : 410B - 410B
  • [33] Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
    Qian, C.
    Wang, Y.
    Reppel, L.
    D'aveni, M.
    Campidelli, A.
    Decot, V.
    Bensoussan, D.
    BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 114 - 122
  • [34] Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
    C Qian
    Y Wang
    L Reppel
    M D'aveni
    A Campidelli
    V Decot
    D Bensoussan
    Bone Marrow Transplantation, 2018, 53 : 114 - 122
  • [35] EFFECT OF INHALED CORTICOSTEROIDS ON EBV-SPECIFIC CYTOTOXIC T-CELLS AND EBV OROPHARYNGEAL EXCRETION
    ABO, W
    IMAI, S
    SUGIURA, M
    TERAI, N
    OSATO, T
    SHIMANO, Y
    CHIBA, S
    LANCET, 1992, 340 (8819): : 606 - 606
  • [36] SITE SPECIFIC INFLAMMATORY T-CELLS IN MYCOBACTERIAL INFECTIONS
    MANCA, F
    VALLE, MT
    COSTANTINI, MT
    HUYGEN, K
    DEBRUYN, J
    DAMIANI, G
    CALTABELLOTTA, M
    ROSSI, G
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1990, 10 (04): : 187 - 187
  • [37] CMV-specific donor T cells for the treatment of recurrent CMV infections in transplanted patients
    Tonn, T.
    Grigoleit, G. U.
    Busch, D.
    Germeroth, L.
    Schuly, N.
    Anderl, F.
    Odendahl, M.
    Seifried, E.
    Einsele, H.
    VOX SANGUINIS, 2008, 95 : 203 - 203
  • [38] UNASSISTED PRODUCTION OF CLINICAL-GRADE VIRAL-SPECIFIC T CELLS: BRINGING PRODUCTION TO THE BEDSIDE
    Kumar, P.
    Figliola, M.
    Maiti, S.
    Huls, M. H.
    Kontoyiannis, D.
    Tewari, P.
    Richter, A.
    Kaltz, N.
    Champlin, R.
    Cooper, L.
    CYTOTHERAPY, 2016, 18 (06) : S22 - S22
  • [39] Tissue-specific control of latent CMV reactivation by regulatory T cells
    Almanan, Maha
    Raynor, Jana
    Sholl, Allyson
    Wang, Mei
    Chougnet, Claire
    Cardin, Rhonda D.
    Hildeman, David A.
    PLOS PATHOGENS, 2017, 13 (08)
  • [40] Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT
    Krol, L.
    Stuchly, J.
    Hubacek, P.
    Keslova, P.
    Sedlacek, P.
    Stary, J.
    Hrusak, O.
    Kalina, T.
    BONE MARROW TRANSPLANTATION, 2011, 46 (08) : 1089 - 1098
12345